Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ESAB CorpESAB · Entity 3958 | Director · President and CEO | June 10, 2026 | June 12, 2026 |
| Enovis CORPCFX · Entity 4797 | ESAB President and EVP, Colfax | March 07, 2022 | March 09, 2022 |
| Veralto CorpVLTO · Entity 3203 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ESAB Corp
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $82.92 · Expires 2033-06-09 | Direct | 580,552 |
Reported balance
After 2026-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 580,552 · Balance 580,552 F1: The performance stock option to purchase up to 580,552 shares of ESAB common stock vests in three tranches based on ESAB's satisfaction of certain performance criteria during the four-year period commencing on the second anniversary of the grant date and ending on the sixth anniversary of the grant date, subject to the reporting person's continued service through the later of each of the fourth, fifth and sixth anniversaries of the grant date and the date on which ESAB's achievement of the applicable performance criteria has been certified. |
Filing footnotes · ownership attribution and instrument terms
F1: The performance stock option to purchase up to 580,552 shares of ESAB common stock vests in three tranches based on ESAB's satisfaction of certain performance criteria during the four-year period commencing on the second anniversary of the grant date and ending on the sixth anniversary of the grant date, subject to the reporting person's continued service through the later of each of the fourth, fifth and sixth anniversaries of the grant date and the date on which ESAB's achievement of the applicable performance criteria has been certified.
Enovis CORP
Report date March 07, 2022 · Filed March 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $.001SEC Table I · non-derivative | Direct | 100,985 |
Reported balance
After 2022-03-07 transaction · row 1
1 source rowRow 1 · 2022-03-07 · Sale · Disposed 2,788 · Balance 100,985 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.
Veralto Corp
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,470 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 1,099 · Balance 3,470 F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.00 · Expires 2036-07-15 | Direct | 9,413 |
Reported balance
After 2026-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-15 · Grant · Acquired 3,553 · Balance 9,413 F2: The options granted to our non-employee directors will be fully vested as of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
F2: The options granted to our non-employee directors will be fully vested as of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2023 Filed Mar 7, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 2,251 | $60.68 | $136,590.68 |
DisclosureSEC source: 0001209191-23-016926 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,370 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 4,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016926 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 11,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013824 · doc4.xml · derivative · entry 6 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 11,437 shares Expires 2023-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F4 · derivative.exercise_date: In connection with the Company's separation from Colfax Corporation ("Colfax") on April 4, 2022, the reporting person's Colfax performance-based restricted stock units were converted into ESAB time-based restricted stock units. These ESAB restricted stock units represent converted Colfax performance-based restricted stock units that vested in full on February 24, 2023. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 2,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013824 · doc4.xml · derivative · entry 5 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 2,722 shares Expires 2023-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: These restricted stock units vested in full on February 24, 2023. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 5,525 | $57.24 | $316,251.00 |
DisclosureSEC source: 0001209191-23-013824 · doc4.xml · nonDerivative · entry 4 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,962 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 11,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-013824 · doc4.xml · nonDerivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 1,315 | $57.24 | $75,270.60 |
DisclosureSEC source: 0001209191-23-013824 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,050 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 2,722 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-013824 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 2,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012851 · doc4.xml · derivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510 Underlying: Common stock, par value $0.001 · 2,509 shares Expires 2024-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: These restricted stock units vested on February 22, 2023. The remaining restricted stock units will vest on February 22, 2024. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 1,212 | $57.32 | $69,471.84 |
DisclosureSEC source: 0001209191-23-012851 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,643 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 2,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-012851 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:01 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011829 · doc4.xml · derivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,825 Underlying: Common stock, par value $0.001 · 2,412 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: One-third of these restricted stock units vested on February 17, 2023. The remaining restricted stock units will vest in two equal annual installments on February 17, 2024 and February 17, 2025. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:01 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 1,199 | $58.60 | $70,261.40 |
DisclosureSEC source: 0001209191-23-011829 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,346 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:01 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 2,412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-011829 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 3,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061504 · doc4.xml · derivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 3,930 shares Expires 2022-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: These restricted stock units vested in a single installment on December 13, 2022. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 1,899 | $47.79 | $90,753.21 |
DisclosureSEC source: 0001209191-22-061504 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,133 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 3,930 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-061504 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:01 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 37,070 | $0.00 Strike: $49.40 | $0.00 |
DisclosureSEC source: 0001209191-22-029281 · doc4.xml · derivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,070 Underlying: Common stock, par value $0.001 · 37,070 shares Expires 2029-05-11 F4 · derivative.exercise_date: These employee stock options vest and become exercisable in three equal, annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:01 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 32,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029281 · doc4.xml · derivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,389 Underlying: Common stock, par value $0.001 · 32,389 shares Expires 2027-05-12 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · derivative.exercise_date: These restricted stock units vest in three equal, annual installments beginning on the third anniversary of the grant date. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:01 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 35,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029281 · doc4.xml · derivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,425 Underlying: Common stock, par value $0.001 · 35,425 shares Expires 2025-05-12 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F2 · derivative.exercise_date: These restricted stock units vest in three equal, annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 46,562 | $0.00 Strike: $41.63 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 12 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,562 Underlying: Common stock, par value $0.001 · 46,562 shares Expires 2025-03-07 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 33,800 | $0.00 Strike: $50.43 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 11 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,800 Underlying: Common stock, par value $0.001 · 33,800 shares Expires 2024-02-12 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 24,888 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 10 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888 Underlying: Common stock, par value $0.001 · 24,888 shares Expires 2027-02-23 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F12 · derivative.exercise_date: 20,679 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 59,404 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 9 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,404 Underlying: Common stock, par value $0.001 · 59,404 shares Expires 2026-02-24 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 19,153 | $0.00 Strike: $51.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 8 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,153 Underlying: Common stock, par value $0.001 · 19,153 shares Expires 2029-02-16 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F11 · derivative.exercise_date: These shares of the option will fully vest and become exercisable in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 18,539 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 7 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,539 Underlying: Common stock, par value $0.001 · 18,539 shares Expires 2028-02-21 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10 · derivative.exercise_date: 7,702 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 9,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 6 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,319 Underlying: Common stock, par value $0.001 · 9,319 shares Expires 2024-03-05 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F8 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on March 5, 2023 and March 5, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 7,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 5 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,237 Underlying: Common stock, par value $0.001 · 7,237 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 5,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 4 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,019 Underlying: Common stock, par value $0.001 · 5,019 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 2,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,722 Underlying: Common stock, par value $0.001 · 2,722 shares Expires 2023-02-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 3,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 Underlying: Common stock, par value $0.001 · 3,930 shares Expires 2022-12-13 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on December 13, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC | ESAB Corp ESAB · Entity 3958 | GrantCommon stock, par value $0.001 | 24,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,102 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 23:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 2,788 | $38.88 | $108,397.44 |
DisclosureSEC source: 0001209191-22-017661 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 21,190 | $41.27 | $874,511.30 |
DisclosureSEC source: 0001209191-22-014363 · doc4.xml · nonDerivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,773 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 44,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014363 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,963 F2 · kind: Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021. F2 · shares: Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,629 | $42.18 | $68,711.22 |
DisclosureSEC source: 0001209191-22-014363 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,533 | $41.83 | $64,125.39 |
DisclosureSEC source: 0001209191-22-013295 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,447 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 23,870 | $0.00 Strike: $41.70 | $0.00 |
DisclosureSEC source: 0001209191-22-011935 · doc4.xml · derivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,870 Underlying: Common stock, par value $.001 · 23,870 shares Expires 2029-02-17 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 9,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011935 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,980 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 2,366 | $44.33 | $104,884.78 |
DisclosureSEC source: 0001209191-21-069828 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person to meet tax obligations relating to the vesting of restricted stock units granted to the reporting person on December 13, 2019. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person to meet tax obligations relating to the vesting of restricted stock units granted to the reporting person on December 13, 2019. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 24,644 | $0.00 Strike: $24.96 | $0.00 |
DisclosureSEC source: 0001209191-21-060972 · doc4.xml · derivative · entry 4 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $.001 · 24,644 shares Expires 2023-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 5/13/2016. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 15,218 | $50.68 | $771,293.89 |
DisclosureSEC source: 0001209191-21-060972 · doc4.xml · nonDerivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,327 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.05 to $51.03, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 24,644 | $50.69 | $1,249,229.00 |
DisclosureSEC source: 0001209191-21-060972 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,545 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.04 to $51.04, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 24,644 | $24.96 | $615,114.24 |
DisclosureSEC source: 0001209191-21-060972 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 8,544 | $46.74 | $399,346.56 |
DisclosureSEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 4 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,545 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 3,353 | $46.74 | $156,719.22 |
DisclosureSEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,089 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 17,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,442 F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 6,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,752 F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 17,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-019307 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,811 F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 25, 2021 Filed Feb 27, 2021 02:01 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,850 | $46.01 | $85,118.50 |
DisclosureSEC source: 0001209191-21-015062 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,389 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.